Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cimzia (Certolizumab Pegol) Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project

NCT01797224 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT01797224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01797224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cimzia (Certolizumab Pegol) Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project
Lead sponsor
University of California, San Diego
Phase
Observational
Overall status
Active, not recruiting
Start date
March 31, 2012
Completion date
March 31, 2026
Enrollment
925 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, crohn's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis